{"disease":{"id":"cornea","name":"cornea"},"drugs":{"marketed":[{"drug_id":"prednisone","indication_name":"Allergic corneal marginal ulcers","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Deltasone","generic_name":"prednisone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone-phosphate","indication_name":"Allergic corneal marginal ulcers","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dexamethasone Sodium Phosphate","generic_name":"dexamethasone phosphate","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Androgen receptor, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"cysteamine-hydrochloride","indication_name":"Corneal cystine crystal deposits in cystinosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CYSTEAMINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"Cystine","drug_class":"Cystine-depleting agents","quality_score":44,"revenue":null,"mechanism":"Cysteamine depletes cystine by converting it to cysteine and cysteine-cysteamine mixed disulfides, reducing corneal cystine crystal accumulation."},{"drug_id":"loteprednol-etabonate-and-tobramycin","indication_name":"Corneal injury from chemical, radiation, or thermal burns","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"loteprednol etabonate and tobramycin","company_name":"Bausch & Lomb Incorporated","drug_phase":"marketed","molecular_target":"","drug_class":"Aminoglycoside Antibacterial [EPC]","quality_score":31,"revenue":null,"mechanism":null},{"drug_id":"fusidic-acid","indication_name":"Corneal abrasion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ramycin","generic_name":"FUSIDIC ACID","company_name":"","drug_phase":"phase_3","molecular_target":"Bile salt export pump","drug_class":"fusidic acid","quality_score":47,"revenue":null,"mechanism":"Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins."},{"drug_id":"fusidic-acid","indication_name":"Perforation of cornea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ramycin","generic_name":"FUSIDIC ACID","company_name":"","drug_phase":"phase_3","molecular_target":"Bile salt export pump","drug_class":"fusidic acid","quality_score":47,"revenue":null,"mechanism":"Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins."},{"drug_id":"bacitracin","indication_name":"Corneal abrasion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortisporin","generic_name":"BACITRACIN","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Tyrosine-protein kinase Lck","drug_class":"bacitracin","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"loteprednol-etabonate","indication_name":"Corneal abrasion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lotemax","generic_name":"LOTEPREDNOL ETABONATE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"loteprednol-etabonate","indication_name":"Perforation of cornea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lotemax","generic_name":"LOTEPREDNOL ETABONATE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"tobramycin","indication_name":"Corneal abrasion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tobi","generic_name":"tobramycin","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Taste receptor type 2 member 20, Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)","drug_class":"","quality_score":40,"revenue":null,"mechanism":null},{"drug_id":"tobramycin","indication_name":"Perforation of cornea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tobi","generic_name":"tobramycin","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Taste receptor type 2 member 20, Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)","drug_class":"","quality_score":40,"revenue":null,"mechanism":null},{"drug_id":"fluorometholone","indication_name":"Corneal abrasion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fml","generic_name":"FLUOROMETHOLONE","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"fluorometholone","indication_name":"Corneal ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fml","generic_name":"FLUOROMETHOLONE","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"hydrocortisone-acetate","indication_name":"Corneal abrasion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortifoam","generic_name":"HYDROCORTISONE ACETATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"medrysone","indication_name":"Corneal abrasion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Medrifar","generic_name":"MEDRYSONE","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"medrysone","indication_name":"Corneal ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Medrifar","generic_name":"MEDRYSONE","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"cortisone-acetate","indication_name":"Corneal abrasion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortone","generic_name":"CORTISONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"cortisone-acetate","indication_name":"Corneal ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortone","generic_name":"CORTISONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"lotemax","indication_name":"Corneal abrasion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lotemax","company_name":"Tufts Medical Center","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"lotemax","indication_name":"Perforation of cornea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lotemax","company_name":"Tufts Medical Center","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"dexamethasone","indication_name":"Corneal abrasion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Decadron","generic_name":"dexamethasone","company_name":"Generic (originally Merck)","drug_phase":"marketed","molecular_target":"Annexin A1, Interleukin-4, Androgen receptor","drug_class":"Corticosteroid [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone","indication_name":"Corneal ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Decadron","generic_name":"dexamethasone","company_name":"Generic (originally Merck)","drug_phase":"marketed","molecular_target":"Annexin A1, Interleukin-4, Androgen receptor","drug_class":"Corticosteroid [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone","indication_name":"Perforation of cornea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Decadron","generic_name":"dexamethasone","company_name":"Generic (originally Merck)","drug_phase":"marketed","molecular_target":"Annexin A1, Interleukin-4, Androgen receptor","drug_class":"Corticosteroid [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"ciprofloxacine","indication_name":"Bacterial Corneal Ulcer Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ciprofloxacine","company_name":"Poitiers University Hospital","drug_phase":"discontinued","molecular_target":"DNA topoisomerase II, DNA gyrase subunit A, DNA gyrase subunit A","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"tobramycin-sulfate","indication_name":"Corneal abrasion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vantobra","generic_name":"Tobramycin Sulfate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Taste receptor type 2 member 20","drug_class":"tobramycin","quality_score":68,"revenue":null,"mechanism":""},{"drug_id":"tobramycin-sulfate","indication_name":"Perforation of cornea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vantobra","generic_name":"Tobramycin Sulfate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Taste receptor type 2 member 20","drug_class":"tobramycin","quality_score":68,"revenue":null,"mechanism":""},{"drug_id":"nebcin","indication_name":"Corneal abrasion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Nebcin","company_name":"University Hospital, Lille","drug_phase":"discontinued","molecular_target":"Taste receptor type 2 member 20, Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"nebcin","indication_name":"Perforation of cornea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Nebcin","company_name":"University Hospital, Lille","drug_phase":"discontinued","molecular_target":"Taste receptor type 2 member 20, Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"neomycin","indication_name":"Corneal abrasion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortisporin","generic_name":"NEOMYCIN","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Transient receptor potential cation channel subfamily V member 1","drug_class":"Aminoglycoside Antibacterial","quality_score":53,"revenue":null,"mechanism":""},{"drug_id":"hydrocortisone","indication_name":"Corneal abrasion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortef","generic_name":"hydrocortisone","company_name":"Generic (originally Merck/Upjohn)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"hydrocortisone","indication_name":"Corneal ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortef","generic_name":"hydrocortisone","company_name":"Generic (originally Merck/Upjohn)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"polymyxin-b","indication_name":"Corneal abrasion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortisporin","generic_name":"POLYMYXIN B","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"","drug_class":"Polymyxin-class Antibacterial","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"fluorometholone-acetate","indication_name":"Corneal abrasion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Flarex","generic_name":"FLUOROMETHOLONE ACETATE","company_name":"Harrow Health","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":39,"revenue":null,"mechanism":""},{"drug_id":"fluorometholone-acetate","indication_name":"Corneal ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Flarex","generic_name":"FLUOROMETHOLONE ACETATE","company_name":"Harrow Health","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":39,"revenue":null,"mechanism":""},{"drug_id":"norfloxacin","indication_name":"Bacterial Corneal Ulcer Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Noroxin","generic_name":"NORFLOXACIN","company_name":"","drug_phase":"marketed","molecular_target":"Gamma-aminobutyric acid receptor subunit alpha-1","drug_class":"Quinolone Antimicrobial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"ofloxacin","indication_name":"Bacterial Corneal Ulcer Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Floxin","generic_name":"OFLOXACIN","company_name":"","drug_phase":"marketed","molecular_target":"Histamine H3 receptor","drug_class":"Quinolone Antimicrobial [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"ciprofloxacin","indication_name":"Bacterial Corneal Ulcer Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cipro","generic_name":"ciprofloxacin","company_name":"Bayer AG","drug_phase":"marketed","molecular_target":"DNA topoisomerase II, DNA gyrase subunit A, DNA gyrase subunit A","drug_class":"Fluoroquinolone antibiotic","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"tetracaine","indication_name":"Administration of Corneal Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tetracaine Hydrochloride","generic_name":"TETRACAINE","company_name":"Alcon Labs","drug_phase":"marketed","molecular_target":"Sodium channel protein type 7 subunit alpha","drug_class":"Ester Local Anesthetic","quality_score":10,"revenue":null,"mechanism":"Tetracaine Hydrochloride works by blocking sodium channels in nerve cells to prevent pain signals from being transmitted."},{"drug_id":"levofloxacin","indication_name":"Bacterial Corneal Ulcer Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Levaquin","generic_name":"levofloxacin","company_name":"Generic (originally Daiichi Sankyo/J&J)","drug_phase":"marketed","molecular_target":"CAAX prenyl protease 2, Multidrug and toxin extrusion protein 1, Potassium voltage-gated channel subfamily H member 2","drug_class":"Fluoroquinolone Antibacterial [EPC]","quality_score":65,"revenue":null,"mechanism":"Levofloxacin is a fluoroquinolone antibacterial agent."},{"drug_id":"cortisol","indication_name":"Corneal abrasion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cortisol","company_name":"University of Zurich","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"cortisol","indication_name":"Corneal ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cortisol","company_name":"University of Zurich","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prednisolone","indication_name":"Corneal abrasion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prelone","generic_name":"prednisolone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"Glucocorticoid (corticosteroid)","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"prednisolone","indication_name":"Corneal ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prelone","generic_name":"prednisolone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"Glucocorticoid (corticosteroid)","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"prednisolon","indication_name":"Corneal abrasion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednisolon","company_name":"Hannover Medical School","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prednisolon","indication_name":"Corneal ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednisolon","company_name":"Hannover Medical School","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"ofloxacine","indication_name":"Bacterial Corneal Ulcer Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ofloxacine","company_name":"Assistance Publique - Hôpitaux de Paris","drug_phase":"phase_3","molecular_target":"Gamma-aminobutyric acid receptor subunit alpha-2, Histamine H3 receptor, Muscarinic acetylcholine receptor M1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"proxymetacaine","indication_name":"Administration of Corneal Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Proxymetacaine","company_name":"Medical University of Silesia","drug_phase":"phase_1","molecular_target":"Amine oxidase [flavin-containing] A, Sigma non-opioid intracellular receptor 1, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":47,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03381794","title":"The German Keratoplasty Registry of the German Ophthalmological Society (DOG)","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Universität des Saarlandes","has_results":false},{"nct_id":"NCT04763785","title":"Development of a Keratoconus Detection Algorithm by Deep Learning Analysis and Its Validation on Eyestar Images","phase":"","overall_status":"UNKNOWN","enrollment_count":4800,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT06348368","title":"Refractive and Corneal Topographic Characteristics in Upper Egypt Children With High Cylinder","phase":"","overall_status":"COMPLETED","enrollment_count":4000,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT00001310","title":"Tissue Studies of Human Eye Diseases","phase":"","overall_status":"TERMINATED","enrollment_count":3833,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT06211218","title":"Artificial Intelligence for Screening of Multiple Corneal Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Tianjin Eye Hospital","has_results":false},{"nct_id":"NCT06220578","title":"Analysis of Topographic Corneal Parameters","phase":"","overall_status":"COMPLETED","enrollment_count":2694,"lead_sponsor_name":"Minia University","has_results":false},{"nct_id":"NCT03029104","title":"Collagen Cross-Linking With Ultraviolet-A in Asymmetric Corneas","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":2228,"lead_sponsor_name":"Cxlusa","has_results":true},{"nct_id":"NCT06830538","title":"Study of the Anatomical and Functional Recovery and Quality of Life of Patients Undergoing Corneal Transplantation","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT07117071","title":"Prevalence of Fuchs Endothelial Corneal Dystrophy in a Population of Dermatology Patients.","phase":"","overall_status":"COMPLETED","enrollment_count":1200,"lead_sponsor_name":"Centre Hospitalier Universitaire de Saint Etienne","has_results":false},{"nct_id":"NCT01537393","title":"Cornea Preservation Time Study","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1174,"lead_sponsor_name":"Case Western Reserve University","has_results":true},{"nct_id":"NCT05134480","title":"Impact of Donor Diabetes on DMEK Success and Endothelial Cell Loss","phase":"NA","overall_status":"COMPLETED","enrollment_count":1097,"lead_sponsor_name":"Case Western Reserve University","has_results":true},{"nct_id":"NCT06491615","title":"National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT06859411","title":"Prognosis of Posterior Lamellar Keratoplasty, an Observational Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Centre Hospitalier Régional Metz-Thionville","has_results":false},{"nct_id":"NCT04164407","title":"Keratoconus, Corneal Diseases and Transplant Registry","phase":"","overall_status":"UNKNOWN","enrollment_count":800,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT04251143","title":"Dresden Corneal Disease and Treatment Study","phase":"","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"Technische Universität Dresden","has_results":false},{"nct_id":"NCT00008541","title":"Evaluation and Treatment of Patients With Corneal and External Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT07217249","title":"Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 Years","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":570,"lead_sponsor_name":"Case Western Reserve University","has_results":false},{"nct_id":"NCT03922542","title":"Comparison of Standard vs. Accelerated Corneal Crosslinking","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":510,"lead_sponsor_name":"Price Vision Group","has_results":false},{"nct_id":"NCT04094090","title":"Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Goodman Eye Center","has_results":false},{"nct_id":"NCT06160960","title":"Influence of Pupillary Behavior During Eye Surgery on Morphological and Functional Outcome","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Klinikum Klagenfurt am Wörthersee","has_results":false},{"nct_id":"NCT05742321","title":"Analysis of the Genotype/Phenotype Relationship in the Fuchs' Corneal Endothelial Dystrophy in France","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Centre Hospitalier Universitaire de Saint Etienne","has_results":false},{"nct_id":"NCT06881771","title":"FECD-TRACE: Fuchs' Endothelial Corneal Dystrophy TRAjectory and Correlation With Genotype in the United Kingdom","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT05255016","title":"Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":488,"lead_sponsor_name":"Peschke GmbH","has_results":false},{"nct_id":"NCT03791619","title":"Post-Approval Study of the TECNIS SYMFONY® Toric Lenses","phase":"NA","overall_status":"COMPLETED","enrollment_count":475,"lead_sponsor_name":"Johnson & Johnson Surgical Vision, Inc.","has_results":true},{"nct_id":"NCT05255107","title":"Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":468,"lead_sponsor_name":"Peschke GmbH","has_results":false},{"nct_id":"NCT03504800","title":"OCT in Diagnosis of Irregular Corneas","phase":"","overall_status":"RECRUITING","enrollment_count":445,"lead_sponsor_name":"Oregon Health and Science University","has_results":false},{"nct_id":"NCT05653921","title":"Prospective Study to Validate the Imaging Biomarker for NCP (R33)","phase":"","overall_status":"SUSPENDED","enrollment_count":438,"lead_sponsor_name":"Tufts Medical Center","has_results":false},{"nct_id":"NCT04011696","title":"Monofocal Extended Range of Vision (MERoV) Study","phase":"","overall_status":"COMPLETED","enrollment_count":412,"lead_sponsor_name":"Brighton and Sussex University Hospitals NHS Trust","has_results":false},{"nct_id":"NCT04475900","title":"Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics","phase":"","overall_status":"COMPLETED","enrollment_count":372,"lead_sponsor_name":"Technische Universität Dresden","has_results":false},{"nct_id":"NCT03655743","title":"PRO Measure for Refractive Surgery IRAS Project Number 246072","phase":"","overall_status":"COMPLETED","enrollment_count":372,"lead_sponsor_name":"Moorfields Eye Hospital NHS Foundation Trust","has_results":false},{"nct_id":"NCT04393740","title":"Contribution of Posterior Corneal Astigmatism to Total Corneal Astigmatism in a Sample of Egyptian Population","phase":"","overall_status":"UNKNOWN","enrollment_count":356,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT05528172","title":"A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":331,"lead_sponsor_name":"Kowa Research Institute, Inc.","has_results":false},{"nct_id":"NCT02128113","title":"RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":307,"lead_sponsor_name":"Biogen","has_results":true},{"nct_id":"NCT05075746","title":"Retrospective Chart Review of enVista Toric 0.9D Intraocular Lenses","phase":"","overall_status":"COMPLETED","enrollment_count":302,"lead_sponsor_name":"Bausch & Lomb Incorporated","has_results":true},{"nct_id":"NCT04401865","title":"Safety and Effectiveness of the PXL-Platinum 330 System","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Colorado Eye Consultants/Cornea Consultants of Colorado","has_results":false},{"nct_id":"NCT07518316","title":"Factors Influencing Subjective Visual Quality in Human Eyes","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Tianjin Eye Hospital","has_results":false},{"nct_id":"NCT04421300","title":"A Randomized Study of Smile Exercise for Dry Eye","phase":"NA","overall_status":"COMPLETED","enrollment_count":299,"lead_sponsor_name":"Zhongshan Ophthalmic Center, Sun Yat-sen University","has_results":false},{"nct_id":"NCT05985304","title":"Clinical Trial of a Hydrophilic EMV Toric Lens RAO210T in the Correction of Aphakia and Corneal Astigmatism","phase":"NA","overall_status":"COMPLETED","enrollment_count":274,"lead_sponsor_name":"Rayner Intraocular Lenses Limited","has_results":true},{"nct_id":"NCT03949335","title":"Clinical Investigation of the Safety and Effectiveness of an Investigational Model of the TECNIS® Intraocular Lens","phase":"NA","overall_status":"COMPLETED","enrollment_count":272,"lead_sponsor_name":"Johnson & Johnson Surgical Vision, Inc.","has_results":true},{"nct_id":"NCT04837534","title":"Improving the Follow up Rate for Pediatric Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":264,"lead_sponsor_name":"Seva Foundation","has_results":false},{"nct_id":"NCT04667572","title":"Safety & Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":249,"lead_sponsor_name":"Cornea Associates of Texas","has_results":false},{"nct_id":"NCT03473847","title":"Repeatability, Reproducibility and Comparison of Cirrus OCT, RTVue OCT, MS-39 OCT, and Insight 100 VHFDU","phase":"NA","overall_status":"SUSPENDED","enrollment_count":242,"lead_sponsor_name":"London Vision Clinic","has_results":false},{"nct_id":"NCT04890249","title":"Clinical Investigation of Two Tecnis Investigational Lenses","phase":"NA","overall_status":"COMPLETED","enrollment_count":221,"lead_sponsor_name":"Johnson & Johnson Surgical Vision, Inc.","has_results":false},{"nct_id":"NCT05436665","title":"The Belgian Endothelial Surgical Transplant of the Cornea","phase":"NA","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"University Hospital, Antwerp","has_results":false},{"nct_id":"NCT04424550","title":"Comparative Results After DSAEK, UT-DSAEK and DMEK for Fuchs Endothelial Corneal Dystophy","phase":"","overall_status":"COMPLETED","enrollment_count":218,"lead_sponsor_name":"Centre Hospitalier Régional Metz-Thionville","has_results":false},{"nct_id":"NCT03974230","title":"Analysis of the Genotype/Phenotype Relationship in the Fuchs' Corneal Endothelial Dystrophy in France.","phase":"","overall_status":"COMPLETED","enrollment_count":208,"lead_sponsor_name":"Centre Hospitalier Universitaire de Saint Etienne","has_results":false},{"nct_id":"NCT06991374","title":"Study on the Surgical Strategy of Corneal Endothelial Protection for Hard Nuclear Cataract Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":207,"lead_sponsor_name":"Eye & ENT Hospital of Fudan University","has_results":false},{"nct_id":"NCT04177082","title":"Safety and Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Cornea Associates of Texas","has_results":false},{"nct_id":"NCT05447845","title":"Rapid Computerized Visual Acuity Test","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Rambam Health Care Campus","has_results":false},{"nct_id":"NCT04791696","title":"Risk Factors for Human Corneal Graft Failure : a Monocentric Retrospective Observational Cohort","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}